Arisa Asano

844 total citations
18 papers, 650 citations indexed

About

Arisa Asano is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Arisa Asano has authored 18 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Hematology and 4 papers in Immunology. Recurrent topics in Arisa Asano's work include Retinoids in leukemia and cellular processes (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Arisa Asano is often cited by papers focused on Retinoids in leukemia and cellular processes (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Arisa Asano collaborates with scholars based in Japan, United States and Ireland. Arisa Asano's co-authors include Madeleine Duvic, Roshantha A.S. Chandraratna, Sunil Nagpal, James M. Musser, Clotilde M. Jackow, Jennifer Clay Cather, A. T. Charlie Johnson, Steven R. Mays, C Hager and Monica Malhotra and has published in prestigious journals such as Blood, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Arisa Asano

16 papers receiving 617 citations

Peers

Arisa Asano
Kai‐Lin Yan China
Masahiro Takigawa Japan
Yi Fritz United States
Sothy Yi United States
Hideaki Sugiyama Japan
M. Carducci Italy
Changsheng Guo China
C. Ferraro Italy
Yuki Ichimura Japan
Volker Blaschke Germany
Kai‐Lin Yan China
Arisa Asano
Citations per year, relative to Arisa Asano Arisa Asano (= 1×) peers Kai‐Lin Yan

Countries citing papers authored by Arisa Asano

Since Specialization
Citations

This map shows the geographic impact of Arisa Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arisa Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arisa Asano more than expected).

Fields of papers citing papers by Arisa Asano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arisa Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arisa Asano. The network helps show where Arisa Asano may publish in the future.

Co-authorship network of co-authors of Arisa Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Arisa Asano. A scholar is included among the top collaborators of Arisa Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arisa Asano. Arisa Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ri, Masaki, Takahiro Nakashima, Arisa Asano, et al.. (2025). Immunosuppressive Effects of Multiple Myeloma‐Derived Extracellular Vesicles Through T Cell Exhaustion. Cancer Science. 116(7). 1861–1870.
2.
Ri, Masaki, Tomoyuki Nakamura, Hirokazu Sasaki, et al.. (2025). Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma. Cancer Science. 117(2). 325–334.
3.
Suzuki, Tomotaka, Hirokazu Sasaki, Arisa Asano, et al.. (2025). Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B‐cell lymphoma. British Journal of Haematology. 207(1). 92–100. 1 indexed citations
4.
Ri, Masaki, Arisa Asano, Shiori Kinoshita, et al.. (2024). Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone. Cancer Medicine. 13(14). e70019–e70019. 1 indexed citations
5.
Suzuki, Tomotaka, Hirokazu Sasaki, Arisa Asano, et al.. (2024). The Impact of MYD88 and/or CD79B Gene Mutations on Central Nervous System Relapse in Patients with Diffuse Large B-Cell Lymphoma. Blood. 144(Supplement 1). 3075–3075. 1 indexed citations
6.
Suzuki, Tomotaka, Takashi Kanamori, Takashi Yoshida, et al.. (2024). Stratifying ‘frail’ Patients Defined By the Simplified Frailty Scale in Multiple Myeloma: Correlation with Clinical Outcomes. Blood. 144(Supplement 1). 3342–3342. 1 indexed citations
7.
Asano, Arisa, Masaki Ri, Ayako Masaki, et al.. (2022). Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients. Hematological Oncology. 41(3). 424–433. 3 indexed citations
8.
Kinoshita, Shiori, Masaki Ri, Arisa Asano, et al.. (2020). Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma. Cancer Science. 111(4). 1333–1343. 20 indexed citations
9.
Sasaki, Hirokazu, Shigeru Kusumoto, Arisa Asano, et al.. (2019). Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 110(1). 119–123. 4 indexed citations
10.
11.
Duvic, Madeleine, Arisa Asano, C Hager, & Steven R. Mays. (1998). The pathogenesis of psoriasis and the mechanism of action of tazarotene. Journal of the American Academy of Dermatology. 39(4). S129–S133. 43 indexed citations
12.
13.
Duvic, Madeleine, Sunil Nagpal, Arisa Asano, & Roshantha A.S. Chandraratna. (1997). Molecular mechanisms of tazarotene action in psoriasis. Journal of the American Academy of Dermatology. 37(2). S18–S24. 14 indexed citations
14.
Duvic, Madeleine, Sunil Nagpal, Arisa Asano, & Roshantha A.S. Chandraratna. (1997). Molecular mechanisms of tazarotene action in psoriasis. Journal of the American Academy of Dermatology. 37(2). S18–S24. 91 indexed citations
15.
16.
Nagpal, Sunil, et al.. (1996). Tazarotene-Induced Gene 1 (TIG1), a Novel Retinoic Acid Receptor-Responsive Gene in Skin. Journal of Investigative Dermatology. 106(2). 269–274. 112 indexed citations
17.
Nagpal, Sunil, Scott M. Thacher, Sylvie Friant, et al.. (1996). Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.. PubMed. 7(12). 1783–91. 54 indexed citations
18.
Asano, Arisa, Sunil Nagpal, Roshantha A.S. Chandraratna, & Madeleine Duvic. (1995). Tazarotene (AGN 190168), a topical retinoid, improves psoriasis and alters epidermal gene expression in vivo.. Journal of Investigative Dermatology. 4(104). 694. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai‐Lin Yan Breakdown of academic impact, for papers by Masahiro Takigawa Breakdown of academic impact, for papers by Yi Fritz Breakdown of academic impact, for papers by Sothy Yi Breakdown of academic impact, for papers by Hideaki Sugiyama Breakdown of academic impact, for papers by M. Carducci Breakdown of academic impact, for papers by Changsheng Guo Breakdown of academic impact, for papers by C. Ferraro Breakdown of academic impact, for papers by Yuki Ichimura Breakdown of academic impact, for papers by Volker Blaschke
Rankless by CCL
2026